PDB Short entry for 5XRA HEADER SIGNALING PROTEIN 08-JUN-17 5XRA TITLE CRYSTAL STRUCTURE OF THE HUMAN CB1 IN COMPLEX WITH AGONIST AM11542 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CANNABINOID RECEPTOR 1,FLAVODOXIN,CANNABINOID RECEPTOR 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 99-306,UNP RESIDUES 3-148,UNP RESIDUES 332- COMPND 5 414; COMPND 6 SYNONYM: CB1,CANN6,CB1,CANN6; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, DESULFOVIBRIO VULGARIS (STRAIN SOURCE 3 HILDENBOROUGH / ATCC 29579 / DSM 644 / NCIMB 8303); SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606, 882; SOURCE 6 STRAIN: HILDENBOROUGH / ATCC 29579 / DSM 644 / NCIMB 8303; SOURCE 7 GENE: CNR1, CNR, DVU_2680; SOURCE 8 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS MEMBRANE PROTEIN, HUMAN G PROTEIN-COUPLED RECEPTOR, STABILIZING KEYWDS 2 AGONISTS, LIPIDIC CUBIC PHASE, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR T.HUA,K.VEMURI,P.S.NIKAS,R.B.LAPRAIRIE,Y.WU,L.QU,M.PU,A.KORDE,J.SHAN, AUTHOR 2 J.H.HO,G.W.HAN,K.DING,X.LI,H.LIU,M.A.HANSON,S.ZHAO,L.M.BOHN, AUTHOR 3 A.MAKRIYANNIS,R.C.STEVENS,Z.J.LIU REVDAT 6 22-NOV-23 5XRA 1 REMARK REVDAT 5 18-OCT-17 5XRA 1 REMARK REVDAT 4 16-AUG-17 5XRA 1 REMARK REVDAT 3 09-AUG-17 5XRA 1 JRNL REVDAT 2 19-JUL-17 5XRA 1 JRNL REVDAT 1 12-JUL-17 5XRA 0 JRNL AUTH T.HUA,K.VEMURI,S.P.NIKAS,R.B.LAPRAIRIE,Y.WU,L.QU,M.PU, JRNL AUTH 2 A.KORDE,S.JIANG,J.H.HO,G.W.HAN,K.DING,X.LI,H.LIU,M.A.HANSON, JRNL AUTH 3 S.ZHAO,L.M.BOHN,A.MAKRIYANNIS,R.C.STEVENS,Z.J.LIU JRNL TITL CRYSTAL STRUCTURES OF AGONIST-BOUND HUMAN CANNABINOID JRNL TITL 2 RECEPTOR CB1 JRNL REF NATURE V. 547 468 2017 JRNL REFN ESSN 1476-4687 JRNL PMID 28678776 JRNL DOI 10.1038/NATURE23272 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.91 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 16669 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.235 REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.830 REMARK 3 FREE R VALUE TEST SET COUNT : 805 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 37.9164 - 5.0847 0.96 2833 150 0.1973 0.1973 REMARK 3 2 5.0847 - 4.0373 0.95 2712 140 0.1998 0.2613 REMARK 3 3 4.0373 - 3.5274 0.95 2670 141 0.2483 0.2639 REMARK 3 4 3.5274 - 3.2051 0.94 2615 141 0.2834 0.2953 REMARK 3 5 3.2051 - 2.9754 0.91 2530 128 0.3411 0.3856 REMARK 3 6 2.9754 - 2.8001 0.90 2504 105 0.3920 0.4027 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.530 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.490 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 3539 REMARK 3 ANGLE : 0.732 4811 REMARK 3 CHIRALITY : 0.040 562 REMARK 3 PLANARITY : 0.004 580 REMARK 3 DIHEDRAL : 17.271 2033 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 104 THROUGH 306 ) REMARK 3 ORIGIN FOR THE GROUP (A): -45.7418-153.3025 304.1440 REMARK 3 T TENSOR REMARK 3 T11: 0.4955 T22: 0.3907 REMARK 3 T33: 0.4658 T12: 0.0257 REMARK 3 T13: -0.0231 T23: -0.0634 REMARK 3 L TENSOR REMARK 3 L11: 4.3323 L22: 1.3921 REMARK 3 L33: 2.6335 L12: 0.1288 REMARK 3 L13: -0.2432 L23: 0.4963 REMARK 3 S TENSOR REMARK 3 S11: 0.0429 S12: 0.3638 S13: -0.2032 REMARK 3 S21: -0.1574 S22: 0.0364 S23: -0.1851 REMARK 3 S31: -0.0318 S32: -0.1245 S33: -0.0875 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 1002 THROUGH 1148 ) REMARK 3 ORIGIN FOR THE GROUP (A): -43.2031-118.0939 257.7939 REMARK 3 T TENSOR REMARK 3 T11: 0.6676 T22: 0.5114 REMARK 3 T33: 0.8596 T12: -0.0197 REMARK 3 T13: 0.0125 T23: 0.0200 REMARK 3 L TENSOR REMARK 3 L11: 6.7869 L22: 5.0614 REMARK 3 L33: 6.1613 L12: -1.9751 REMARK 3 L13: 0.3850 L23: -1.6483 REMARK 3 S TENSOR REMARK 3 S11: -0.0179 S12: -0.2164 S13: 0.3033 REMARK 3 S21: 0.3632 S22: 0.0139 S23: -0.1697 REMARK 3 S31: -0.3488 S32: -0.0999 S33: 0.0210 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 337 THROUGH 414 ) REMARK 3 ORIGIN FOR THE GROUP (A): -36.6663-150.5189 299.6294 REMARK 3 T TENSOR REMARK 3 T11: 0.5129 T22: 0.6980 REMARK 3 T33: 0.7613 T12: 0.0487 REMARK 3 T13: 0.1202 T23: -0.0593 REMARK 3 L TENSOR REMARK 3 L11: 2.0424 L22: 7.0438 REMARK 3 L33: 2.1106 L12: 2.4253 REMARK 3 L13: 1.0435 L23: 1.1763 REMARK 3 S TENSOR REMARK 3 S11: -0.1483 S12: 0.0702 S13: 0.0338 REMARK 3 S21: 0.1335 S22: 0.1464 S23: 0.1466 REMARK 3 S31: -0.1037 S32: 0.2170 S33: 0.0220 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THERE ARE SOME UNKNOWN DENSITIES LOCATED REMARK 3 AT THE END OF THE SIDE CHAIN OF SER152, WHICH MIGHT BE REMARK 3 PHOSPHORYLATION REMARK 3 BUT NOT CHEMICALLY CONFIRMED YET. THEY HAVE NOT BEEN MODELLED. REMARK 4 REMARK 4 5XRA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 19-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1300004019. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16685 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 37.910 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.5 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.56200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.070 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5TGZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CACODYLATE TRIHYDRATE PH REMARK 280 6.4, 300-350 MM C4H4KNAO6, 30% PEG400, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 33.02500 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.45000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 33.02500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 69.45000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: AUTHORS STATE THAT THE BIOLOGICAL UNIT IS UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21980 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 99 REMARK 465 GLU A 100 REMARK 465 ASN A 101 REMARK 465 PHE A 102 REMARK 465 MET A 103 REMARK 465 PRO A 332 REMARK 465 ASP A 333 REMARK 465 GLN A 334 REMARK 465 ALA A 335 REMARK 465 ARG A 336 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 183 CG CD CE NZ REMARK 470 LYS A 232 NZ REMARK 470 LYS A1003 CG CD CE NZ REMARK 470 LYS A1087 CG CD CE NZ REMARK 470 ARG A1145 CZ NH1 NH2 REMARK 470 ILE A1148 CG1 CG2 CD1 REMARK 470 MET A 337 CG SD CE REMARK 470 ARG A 400 CG CD NE CZ NH1 NH2 REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLA A 603 REMARK 610 OLA A 604 REMARK 610 OLC A 605 REMARK 610 OLC A 606 DBREF 5XRA A 99 306 UNP P21554 CNR1_HUMAN 99 306 DBREF 5XRA A 1003 1148 UNP P00323 FLAV_DESVH 3 148 DBREF 5XRA A 356 414 UNP P21554 CNR1_HUMAN 332 414 SEQADV 5XRA ALA A 210 UNP P21554 THR 210 ENGINEERED MUTATION SEQADV 5XRA LYS A 273 UNP P21554 GLU 273 ENGINEERED MUTATION SEQADV 5XRA VAL A 283 UNP P21554 THR 283 ENGINEERED MUTATION SEQADV 5XRA ALA A 1002 UNP P21554 LINKER SEQADV 5XRA TRP A 1098 UNP P00323 TYR 98 ENGINEERED MUTATION SEQADV 5XRA GLU A 340 UNP P21554 ARG 340 ENGINEERED MUTATION SEQRES 1 A 438 GLY GLU ASN PHE MET ASP ILE GLU CYS PHE MET VAL LEU SEQRES 2 A 438 ASN PRO SER GLN GLN LEU ALA ILE ALA VAL LEU SER LEU SEQRES 3 A 438 THR LEU GLY THR PHE THR VAL LEU GLU ASN LEU LEU VAL SEQRES 4 A 438 LEU CYS VAL ILE LEU HIS SER ARG SER LEU ARG CYS ARG SEQRES 5 A 438 PRO SER TYR HIS PHE ILE GLY SER LEU ALA VAL ALA ASP SEQRES 6 A 438 LEU LEU GLY SER VAL ILE PHE VAL TYR SER PHE ILE ASP SEQRES 7 A 438 PHE HIS VAL PHE HIS ARG LYS ASP SER ARG ASN VAL PHE SEQRES 8 A 438 LEU PHE LYS LEU GLY GLY VAL THR ALA SER PHE THR ALA SEQRES 9 A 438 SER VAL GLY SER LEU PHE LEU ALA ALA ILE ASP ARG TYR SEQRES 10 A 438 ILE SER ILE HIS ARG PRO LEU ALA TYR LYS ARG ILE VAL SEQRES 11 A 438 THR ARG PRO LYS ALA VAL VAL ALA PHE CYS LEU MET TRP SEQRES 12 A 438 THR ILE ALA ILE VAL ILE ALA VAL LEU PRO LEU LEU GLY SEQRES 13 A 438 TRP ASN CYS GLU LYS LEU GLN SER VAL CYS SER ASP ILE SEQRES 14 A 438 PHE PRO HIS ILE ASP LYS THR TYR LEU MET PHE TRP ILE SEQRES 15 A 438 GLY VAL VAL SER VAL LEU LEU LEU PHE ILE VAL TYR ALA SEQRES 16 A 438 TYR MET TYR ILE LEU TRP LYS ALA HIS SER HIS ALA VAL SEQRES 17 A 438 ALA LYS ALA LEU ILE VAL TYR GLY SER THR THR GLY ASN SEQRES 18 A 438 THR GLU TYR THR ALA GLU THR ILE ALA ARG GLU LEU ALA SEQRES 19 A 438 ASP ALA GLY TYR GLU VAL ASP SER ARG ASP ALA ALA SER SEQRES 20 A 438 VAL GLU ALA GLY GLY LEU PHE GLU GLY PHE ASP LEU VAL SEQRES 21 A 438 LEU LEU GLY CYS SER THR TRP GLY ASP ASP SER ILE GLU SEQRES 22 A 438 LEU GLN ASP ASP PHE ILE PRO LEU PHE ASP SER LEU GLU SEQRES 23 A 438 GLU THR GLY ALA GLN GLY ARG LYS VAL ALA CYS PHE GLY SEQRES 24 A 438 CYS GLY ASP SER SER TRP GLU TYR PHE CYS GLY ALA VAL SEQRES 25 A 438 ASP ALA ILE GLU GLU LYS LEU LYS ASN LEU GLY ALA GLU SEQRES 26 A 438 ILE VAL GLN ASP GLY LEU ARG ILE ASP GLY ASP PRO ARG SEQRES 27 A 438 ALA ALA ARG ASP ASP ILE VAL GLY TRP ALA HIS ASP VAL SEQRES 28 A 438 ARG GLY ALA ILE PRO ASP GLN ALA ARG MET ASP ILE GLU SEQRES 29 A 438 LEU ALA LYS THR LEU VAL LEU ILE LEU VAL VAL LEU ILE SEQRES 30 A 438 ILE CYS TRP GLY PRO LEU LEU ALA ILE MET VAL TYR ASP SEQRES 31 A 438 VAL PHE GLY LYS MET ASN LYS LEU ILE LYS THR VAL PHE SEQRES 32 A 438 ALA PHE CYS SER MET LEU CYS LEU LEU ASN SER THR VAL SEQRES 33 A 438 ASN PRO ILE ILE TYR ALA LEU ARG SER LYS ASP LEU ARG SEQRES 34 A 438 HIS ALA PHE ARG SER MET PHE PRO SER HET FMN A 601 31 HET 8D3 A 602 28 HET OLA A 603 13 HET OLA A 604 13 HET OLC A 605 17 HET OLC A 606 13 HET PEG A 607 7 HET CLR A 608 28 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM 8D3 (6AR,10AR)-3-(8-BROMANYL-2-METHYL-OCTAN-2-YL)-6,6,9- HETNAM 2 8D3 TRIMETHYL-6A,7,10,10A-TETRAHYDROBENZO[C]CHROMEN-1-OL HETNAM OLA OLEIC ACID HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM CLR CHOLESTEROL HETSYN FMN RIBOFLAVIN MONOPHOSPHATE HETSYN OLC 1-OLEOYL-R-GLYCEROL FORMUL 2 FMN C17 H21 N4 O9 P FORMUL 3 8D3 C25 H37 BR O2 FORMUL 4 OLA 2(C18 H34 O2) FORMUL 6 OLC 2(C21 H40 O4) FORMUL 8 PEG C4 H10 O3 FORMUL 9 CLR C27 H46 O HELIX 1 AA1 ASP A 104 MET A 109 5 6 HELIX 2 AA2 ASN A 112 ARG A 148 1 37 HELIX 3 AA3 TYR A 153 VAL A 179 1 27 HELIX 4 AA4 SER A 185 ARG A 220 1 36 HELIX 5 AA5 ALA A 223 VAL A 228 1 6 HELIX 6 AA6 THR A 229 GLY A 254 1 26 HELIX 7 AA7 ASN A 256 GLN A 261 1 6 HELIX 8 AA8 ASP A 272 VAL A 306 1 35 HELIX 9 AA9 GLY A 1013 ALA A 1029 1 17 HELIX 10 AB1 ALA A 1039 VAL A 1041 5 3 HELIX 11 AB2 ASP A 1070 SER A 1077 1 8 HELIX 12 AB3 LEU A 1078 GLY A 1082 5 5 HELIX 13 AB4 CYS A 1102 GLY A 1116 1 15 HELIX 14 AB5 ASP A 1129 ALA A 1132 5 4 HELIX 15 AB6 ALA A 1133 ALA A 1147 1 15 HELIX 16 AB7 ASP A 338 GLY A 369 1 32 HELIX 17 AB8 ASN A 372 TYR A 397 1 26 HELIX 18 AB9 SER A 401 MET A 411 1 11 SHEET 1 AA1 5 GLU A1032 ASP A1037 0 SHEET 2 AA1 5 LYS A1003 GLY A1009 1 N ILE A1006 O ARG A1036 SHEET 3 AA1 5 LEU A1052 CYS A1057 1 O LEU A1054 N LEU A1005 SHEET 4 AA1 5 LYS A1087 GLY A1094 1 O PHE A1091 N LEU A1055 SHEET 5 AA1 5 GLU A1118 ILE A1119 1 O GLU A1118 N VAL A1088 SHEET 1 AA2 5 GLU A1032 ASP A1037 0 SHEET 2 AA2 5 LYS A1003 GLY A1009 1 N ILE A1006 O ARG A1036 SHEET 3 AA2 5 LEU A1052 CYS A1057 1 O LEU A1054 N LEU A1005 SHEET 4 AA2 5 LYS A1087 GLY A1094 1 O PHE A1091 N LEU A1055 SHEET 5 AA2 5 LEU A1124 ASP A1127 1 O LEU A1124 N CYS A1090 SSBOND 1 CYS A 257 CYS A 264 1555 1555 2.04 CRYST1 66.050 75.870 138.900 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015140 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013180 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007199 0.00000